News

Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute of Technology Center for…
Read More...

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the European Commission has…
Read More...

Takeda Pharmaceutical Company Limited announced it has entered into an agreement to sell its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma Co (Techpool), a leader in…
Read More...

Evotec AG announced today that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in…
Read More...

Avenue Therapeutics announced that its first pivotal Phase 3 trial of IV tramadol achieved the primary endpoint of a statistically significant improvement in Sum of Pain Intensity…
Read More...

Dova Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has completed their Priority Review and approved DOPTELET (avatrombopag) for the treatment of…
Read More...

Harmony Biosciences announced that it has received Breakthrough Therapy and Fast Track designations for its investigational product, pitolisant, from the U.S. Food and Drug…
Read More...

Thermo Fisher Scientific announced Astex Pharmaceuticals selected the Thermo Scientific Glacios Cryo Transmission Electron Microscope (Cryo-TEM) to aid in its drug discovery and…
Read More...

The US Food and Drug Administration (FDA) has approved Lokelma (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of adults with hyperkalaemia, a serious condition…
Read More...

Pfizer announced positive top-line results of a Phase 3 study examining the use of LYRICA (pregabalin) Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric…
Read More...

TEDOR Pharma announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc. DORA Ventures is a newly formed investment…
Read More...

Catalent Pharma Solutions and Valerius Biopharma AG announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar products. Under the agreement,…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. Aimovig is a novel therapeutic…
Read More...

Amneal Pharmaceuticals announced it has received final U.S. Food and Drug Administration (FDA) approval on its Abbreviated New Drug Application for a generic version of Welchol…
Read More...

Albireo Pharma announced the first patient has been enrolled in PEDFIC-1, a Phase 3 clinical trial of lead product candidate A4250, an ileal bile acid transporter (IBAT) inhibitor being…
Read More...

BioLamina and collaborators have partnered with Novo Nordisk A/S (Novo Nordisk), a Danish multinational pharmaceutical company, allowing Novo Nordisk to develop novel stem cell based…
Read More...

Emulate, Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the…
Read More...

The National Institutes of Health is supporting efforts to broaden biomedical scientists’ access to cryo-electron microscopy (cryo-EM), the Nobel Prize-winning (link is external)…
Read More...

The U.S. Food and Drug Administration approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney…
Read More...

Eli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic cluster headache, demonstrating statistically significant…
Read More...